Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Stelara (Ustekinumab) for the Treatment of Moderate to Severe Crohn’s Disease

Drug (Brand / Generic)

Stelara (Ustekinumab)

Product Description

Human monoclonal antibody

Current Indication

Crohn’s disease

Developer

Janssen Biotech

Development Status

Approved in the US and Europe
Expand

Go Top